Jacobs Philip, Bissonnette Robert, Guenther Lyn C
University of Alberta, Edmonton, AB, Canada.
J Rheumatol Suppl. 2011 Nov;88:55-61. doi: 10.3899/jrheum.110901.
Chronic disabling conditions, such as immune-mediated inflammatory diseases (IMID), adversely affect patients in terms of physical suffering and pain, impaired function, and diminished quality of life. These persistent relapsing diseases have a significant influence on individual employment status and work-related productivity. In addition to the significant burden on patients and their families, IMID represent a sizable burden to society due to high healthcare and non-healthcare related costs. Non-healthcare related, or indirect, costs - primarily associated with decreased work productivity, disability payments, and early retirements - are typically greater contributors than direct healthcare costs to the total costs associated with IMID. This article discusses the socioeconomic impact of several IMID, including rheumatoid arthritis, inflammatory bowel disease, ankylosing spondylitis, and psoriasis.
慢性致残性疾病，如免疫介导的炎症性疾病（IMID），在身体疼痛、功能受损和生活质量下降方面对患者产生不利影响。这些持续性复发性疾病对个人就业状况和与工作相关的生产力有重大影响。除了给患者及其家庭带来巨大负担外，由于高昂的医疗保健和非医疗保健相关成本，IMID对社会也构成了相当大的负担。非医疗保健相关或间接成本——主要与工作生产力下降、残疾抚恤金和提前退休有关——通常比直接医疗保健成本对与IMID相关的总成本贡献更大。本文讨论了几种IMID的社会经济影响，包括类风湿性关节炎、炎症性肠病、强直性脊柱炎和银屑病。
